Condition

Malignant Solid Tumor clinical trials and research

• 9Clinical trials
• 5Countries

Newest Malignant Solid Tumor clinical trials

All recruiting trials (9)

• Personalized neoantigen-pulsed dendritic cell injections for malignant solid tumors

  This study tests personalized dendritic cell injections, with or without immune checkpoint inhibitors, to see if they are safe and can help patients with advanced solid tumors.

  Recruiting ZSky Biotech Inc · Qinhuangdao, Hebei · NCT07752953

• FH-006 injection study for advanced solid tumors

  This study tests FH-006, alone and with SHR-1316 and paclitaxel, to see if it is safe and tolerable in adults with unresectable or metastatic solid tumors who have measurable disease.

  Recruiting at 2 sites Phase 1/2 Jiangsu HengRui Medicine Co., Ltd. · Shanghai, Shanghai Municipality and 1 other locations · NCT07136142

• IntraTumor T-Cell Boost with Dual Immune Checkpoint Inhibitors in ARID1A-Mutated Esophageal/Gastric Adenocarcinoma

  A first-in-human test of a single-dose combination of tremelimumab and durvalumab in adults with ARID1A-mutated, non-metastatic esophageal, GEJ, or stomach adenocarcinoma to see if it can increase tumor T cells.

  Recruiting Early Phase 1 University of California, Irvine · Orange, California · NCT06824363

• Testing FH-006 injection in patients with advanced solid tumors

  This study is testing a new injection called FH-006 to see if it can help people with advanced solid tumors who have run out of other treatment options.

  Recruiting Phase 1/2 Jiangsu HengRui Medicine Co., Ltd. · Guangzhou, Guangdong · NCT06735144

• Testing a new treatment for advanced solid tumors

  This study is testing a new treatment called tolododekin alfa for people with advanced solid tumors that haven't improved with standard therapies to see how safe it is and how well it works.

  Recruiting at 5 sites Phase 1 Ankyra Therapeutics, Inc · Bethesda, Maryland and 4 other locations · NCT06171750

• Combining cyclophosphamide, sorafenib, bevacizumab, and atezolizumab for children and young adults with relapsed solid tumors

  This will test whether giving atezolizumab and bevacizumab every three weeks together with daily cyclophosphamide and dose‑adjusted sorafenib is safe and can shrink relapsed or hard‑to‑treat solid tumors in children and young adults, including fibrolamellar carcinoma.

  Recruiting Phase 1/2 St. Jude Children's Research Hospital · Germantown, Tennessee and 1 other locations · NCT05468359

• Testing a new immune therapy for advanced solid tumors resistant to standard treatments

  This study is testing a new immune therapy that uses special cells from patients' tumors to see if it can help people with advanced solid tumors that haven't responded to standard treatments.

  Recruiting Early Phase 1 Vall d'Hebron Institute of Oncology · Barcelona · NCT05141474

• Observational study of Canadian cancer patients with rare molecular alterations

  This study looks at Canadian cancer patients with rare genetic changes in their tumors to see how different treatments work for them and how these cancers behave over time.

  Recruiting at 18 sites University Health Network, Toronto · Calgary, Alberta and 26 other locations · NCT04151342

• Evaluating targeted cancer treatments based on tumor characteristics in advanced tumors

  This study is testing if personalized cancer treatments based on the specific characteristics of a patient's advanced tumor can help them when standard treatments aren't working.

  Recruiting at 9 sites Phase 2 Centre Leon Berard · Angers and 12 other locations · NCT04116541

Related topics

Quick answers

How many Malignant Solid Tumor clinical trials are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in United States (3 trials), China (3 trials), Canada (2 trials), Spain (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Early Phase 1: 2, Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →